Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
ELVN2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in ENLIVEN THERAPEUTICS INC
Yes. Vanguard Portfolio Management holds 562,763 shares of ELVN (Enliven Therapeutics), worth $28.6M, as of its Q2 2026 13F filing. It increased the position by 231,799 shares (+70.0%) from Q1 2026. Vanguard Portfolio Management has held ELVN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$28.6M
Current Shares
562,763
Total Value Change
+$15.6M
Total Shares Change
+231,799
Quarter-by-Quarter History
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.